• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大面积肺栓塞溶栓治疗后患者静息及运动时肺血流动力学的持续改善

Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism.

作者信息

Schwarz F, Stehr H, Zimmermann R, Manthey J, Kübler W

出版信息

Circulation. 1985 Jan;71(1):117-23. doi: 10.1161/01.cir.71.1.117.

DOI:10.1161/01.cir.71.1.117
PMID:3964712
Abstract

This study assessed the long-term effects of thrombolytic treatment in patients with acute massive pulmonary embolism (PE). Seven patients with PE that followed deep-vein thrombosis underwent pulmonary angiography and pressure measurements before and 6 +/- 3 days (mean +/- SD) and 15 +/- 4 months after treatment with intrapulmonary infusions of urokinase (average dose 1724 U/kg X hr) and heparin (average dose 17 U/kg X hr). Treatment was guided by daily measurements of pulmonary arterial (PA) pressure and was continued until PA pressure had normalized (average of 6 days). Late after treatment patients returned for pulmonary angiographic examination, right heart catheterization at rest and during bicycle exercise, and phlebography of the deep veins of both legs. Pulmonary angiograms showed massive obstruction before therapy (Walsh index 15 +/- 2 points of a maximum of 18 points), which was improved 6 days (3 +/- 3 points) and 15 months (1 +/- 2 points) after therapy. Mean PA pressure declined from 37 +/- 9 to 13 +/- 3 mm Hg after 6 days and to 15 +/- 3 mm Hg after 15 months. No recurrence of PE was observed. In six of seven patients at rest and during bicycle exercise (up to 100 W) in the supine position mean PA pressure and total pulmonary resistance remained within normal limits. Over the short term all patients showed clinical signs of deep-vein thrombosis; 15 months later four patients had normal deep veins, but three patients had still phlebographic signs of old thrombosis.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究评估了急性大面积肺栓塞(PE)患者溶栓治疗的长期效果。7例继发于深静脉血栓形成的PE患者,在接受肺内输注尿激酶(平均剂量1724 U/kg·小时)和肝素(平均剂量17 U/kg·小时)治疗前、治疗后6±3天(均值±标准差)和15±4个月,进行了肺血管造影和压力测量。治疗以每日测量肺动脉(PA)压为指导,持续至PA压恢复正常(平均6天)。治疗后期,患者返回接受肺血管造影检查、静息及自行车运动时的右心导管检查,以及双下肢深静脉造影。肺血管造影显示治疗前存在大面积阻塞(Walsh指数为15±2分,最高18分),治疗后6天(3±3分)和15个月(1±2分)有所改善。平均PA压在6天后从37±9降至13±3 mmHg,15个月后降至15±3 mmHg。未观察到PE复发。7例患者中有6例在静息及仰卧位自行车运动(功率达100 W)时,平均PA压和总肺阻力仍在正常范围内。短期内,所有患者均有深静脉血栓形成的临床体征;15个月后,4例患者深静脉正常,但3例患者仍有陈旧性血栓的静脉造影征象。(摘要截短于250字)

相似文献

1
Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism.大面积肺栓塞溶栓治疗后患者静息及运动时肺血流动力学的持续改善
Circulation. 1985 Jan;71(1):117-23. doi: 10.1161/01.cir.71.1.117.
2
Long-term benefit of thrombolytic therapy in patients with pulmonary embolism.溶栓治疗对肺栓塞患者的长期益处。
Vasc Med. 2000;5(2):91-5. doi: 10.1177/1358836X0000500205.
3
[Long-term results after local thrombolysis in acute massive pulmonary embolism].[急性大面积肺栓塞局部溶栓后的长期结果]
Dtsch Med Wochenschr. 1985 Feb 22;110(8):293-7. doi: 10.1055/s-2008-1068815.
4
Mechanical and enzymatic thrombolysis for massive pulmonary embolism.大面积肺栓塞的机械性和酶性溶栓治疗
J Vasc Interv Radiol. 2002 Feb;13(2 Pt 1):163-9. doi: 10.1016/s1051-0443(07)61933-2.
5
[Local thrombolysis with urokinase in acute massive pulmonary embolism].急性大面积肺栓塞的尿激酶局部溶栓治疗
Dtsch Med Wochenschr. 1984 Jan 13;109(2):55-8. doi: 10.1055/s-2008-1069138.
6
Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: a review of 26 patients with and without contraindications to systemic thrombolytic therapy.肺动脉内注入尿激酶治疗大面积肺栓塞:26例有无全身溶栓治疗禁忌证患者的回顾性研究
Clin Cardiol. 1999 Oct;22(10):661-4. doi: 10.1002/clc.4960221014.
7
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.静脉内和肺内注射重组组织型纤溶酶原激活剂治疗急性大面积肺栓塞。
Circulation. 1988 Feb;77(2):353-60. doi: 10.1161/01.cir.77.2.353.
8
Treatment of massive pulmonary thromboembolism with low intrapulmonary dosages of urokinase. Short-term angiographic and hemodynamic evolution.
Chest. 1992 Aug;102(2):341-6. doi: 10.1378/chest.102.2.341.
9
Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.深静脉血栓形成与肺栓塞的病理生理学及治疗
Clin Pharm. 1985 May-Jun;4(3):279-96.
10
Cardiorespiratory efficacy of thrombolytic therapy in acute massive pulmonary embolism: identification of predictive factors.
Eur Respir J. 1999 Mar;13(3):610-5. doi: 10.1183/09031936.99.13361099.

引用本文的文献

1
Impact of catheter fragmentation followed by local intrapulmonary thrombolysis in acute high risk pulmonary embolism as primary therapy.导管破碎联合局部肺内溶栓作为急性高危肺栓塞的初始治疗的影响
Indian Heart J. 2014 May-Jun;66(3):294-301. doi: 10.1016/j.ihj.2014.03.024. Epub 2014 May 13.
2
Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.前瞻性评估急性亚大块肺栓塞后 6 个月右心室功能和功能状态:肺动脉压估计值持续或随后升高的频率。
Chest. 2009 Nov;136(5):1202-1210. doi: 10.1378/chest.08-2988. Epub 2009 Jun 19.